Study Title: Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Kraveka, Jacqueline, at kravekjm@musc.edu.Study Coordinator, Kinder, Hannah, at kinderh@musc.edu.Trial opened at the following institutions: Medical University of South Carolina